2021
DOI: 10.22541/au.162731257.73196581/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Covid-19: acquired acute porphyria?

Abstract: Pandemic Covid-19 pneumonia, of SARS-CoV-2 aetiology, is of global importance to health systems, national economies, and individual civil liberties. Multiple therapeutic and prophylactic agents are currently undergoing clinical trial and, while progress towards a curative agent is promising, the principal limiting factor in public health emergency is time. A pre-existing licensed therapeutic would offer reprieve to international citizens currently enduring the adverse consequences of lockdown policies. The cur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…1,[117][118][119][120] Based on the evidence above, a multiple pathway-hypothesis has been published in the early 2021 to explain erythrocyte and hemoglobin denaturation in these cases. 121 Additionally, considering the possible autoimmune hemolysis (and piastrinopenia) consequent to the viral interaction with RBC receptors (namely CD147 and sialylated membrane glycoproteins), [122][123][124][125] the possibility of free circulating heme has been taken in consideration with reference to the hypothetical pathomechanisms of COVID-19. 1,[126][127][128][129][130][131][132] More recently, an indirect demonstration of the SARS-CoV-2-induced hemolysis has been reported through liquid chromatography, with a documented increase of protoporphyrin IX in blood of COVID-19 patients.…”
Section: Introductionmentioning
confidence: 99%
“…1,[117][118][119][120] Based on the evidence above, a multiple pathway-hypothesis has been published in the early 2021 to explain erythrocyte and hemoglobin denaturation in these cases. 121 Additionally, considering the possible autoimmune hemolysis (and piastrinopenia) consequent to the viral interaction with RBC receptors (namely CD147 and sialylated membrane glycoproteins), [122][123][124][125] the possibility of free circulating heme has been taken in consideration with reference to the hypothetical pathomechanisms of COVID-19. 1,[126][127][128][129][130][131][132] More recently, an indirect demonstration of the SARS-CoV-2-induced hemolysis has been reported through liquid chromatography, with a documented increase of protoporphyrin IX in blood of COVID-19 patients.…”
Section: Introductionmentioning
confidence: 99%